[1] Ferlay J, Shin HR, Bray F, et al. Cancer Incidence and Mortality
Worldwide, International Agency for Research on Cancer, Lyon. (2010).
GLOBOCAN 2008 v1.2.
[2] P. Diaz, S.S. Phatak, J. Xu, F. Astruc-Diaz, C.N. Cavasotto, M. Naguib,
6-MethoxyN-alkyl isatin acylhydrazone derivatives as a novel series of
potent selective cannabinoid receptor 2 inverse agonists: design,
synthesis, and binding mode prediction, J. Med. Chem. 52 433–444
(2009).
[3] S. Costanzi, On the applicability of GPCR homology models to
computer-aided drug discovery: a comparison between in silico and
crystal structures of the beta(2)-adrenergic receptor, J. Med. Chem. 51.
2907–2914 (2008).
[4] Sundberg, R. J. 1970.The Chemistry of Indoles, Academic Press, New
York.
[5] Joule, J. A.; Mills, K. 2000. Heterocyclic Chemistry, 4th ed., Blackwell
Science, Oxford.
[6] Gribble, G. W. J. 2000: Recent developments in indole ring synthesis-methodology
[7] Zhang H.Z.: J. Med. Chem. 48, 5215 (2005).
[8] Ashok Kumar, Hemlata Kaur, Sunil Kumar , “Synthesis, Antipsychotic
and Anticonvulsant Activityof some new pyrazolinyl/isoxazolinylindol-2-ones” Int. J. Chem. Tech. Res. Vol.2, No.2, pp 1010-1019, April-June
2010.
[9] Samosorn S., Bremner J. B., Ball Lewis A.K.: Bioorg. Med. Chem. 14,
857 (2006).
[10] Chang, X., Tou, J.C., Hong, C., Kim, H.A., Riby, J.E., Firestone,
G.L.,Bjeldanes, F., 2005. 3,3-diindolylmethane inhibits angiogenesis
and the growth of transplantable human breast carcinoma in athymic
mice. Carcinogenesis 26, 771–778.
[11] Chen, D.Z., Qi, M., Auborn, K.J., Carter, T.H., 2001. Indole-3-carbinoland diindolylmethane induce apoptosis of human cervical
cancer cells and in murine HPV16-transgenic preneoplastic cervical
epithelium.Journal of Nutrition 131, 3294–3302.
[12] Chinni, S.R., Li, Y., Upadhyay, S., Koppolu, P.K., Sarkar, F.H.,
2001.Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell
cycle arrest and apoptosis in prostate cancer cells. Oncogene 20, 2927–
2936.
[13] Qi, M., et al. Indole-3-carbinol prevents PTEN loss in cervical cancer in
vivo. Mol Med, 2005. 11(1-12): p. 59-63.
[14] Naik, R., et al. A randomized phase II trial of indole-3-carbinol in the
treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer,
2006. 16(2): p. 786-90.
[15] Bell, M.C., et al. Placebo-controlled trial of indole-3-carbinol in the
treatment of CIN. Gynecol Oncol, 2000. 78(2): p. 123-9.
[16] Kietpeerakool, C., and Srisomboon, J. Medical treatment of cervical
intraepithelial neoplasia II, III: an update review. Int J Clin Oncol, 2009.
14(1): p. 37-42.
[17] Kim. Y.S., and Milner, J.A. Targets for indole-3-carbinol in cancer
prevention. J Nutr Biochem, 2005. 16(2): p. 65-73
[18] Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.;
Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.;
Shaw, D. E.; Francis, P.; Shenkin, P. S., 2004, Glide: A new approach
for rapid,
[19] Krovat, E. M.; Steindl, T.; Langer, T., 2005, Recent Advances in
Docking and Scoring. Curr. Comput.-Aided Drug Des., 1, 93-102.
[20] Kontoyianni, M.; McClellan, L. M.; Sokol, G. S., 2004, Evaluation of
Docking Performance: Comparative Data on Docking Algorithms. J.
Med. Chem., 47, 558-565
[21] Maestro, Version 9.2, Schrödinger, LLC, New York, NY, (2012).
[22] Glide, Version 5.7, Schrödinger, LLC, New York, NY, (2012)
Thank you for copying data from http://www.arastirmax.com
